Annual Checkup -- CCEL
I opened my initial position in Cryo-Cell International (CCEL -- click to register for free RT streaming quote) back in mid-November at $3.89, so my shares are a bit depressed at the moment. My full rationale for investing in this private cord-blood stem cell bank is in my recent writeups here and here, but I think 2006 could end up being a very big year for this investment. All of CCEL's competitors have seen a very recent boost in price due to the new Stem Cell Therapeutic and Research Act signed by the President earlier this week that appropriates $300 million for research and infrastructure for umbilical cord stem cells, but CCEL didn't see nearly the same appreciation as most of them. CCEL has the most modern banking facility and one of the largest, if not the largest, client base, and should benefit from the higher profile of stem cell banking as well as the increased awareness of the amazing things that stem cells may possibly be able to do (cure diabetes, etc.) -- even if they don't actually receive any direct governmental funding, which is certainly possible as well. CCEL is launching a new service in 2006 that will further differentiate their offerings -- they will begin banking placental stem cells as well, using a patented and exclusively licensed process, which should help them stand out for expectant parents. Finally, 2006 marks the year that CCEL aims to finish its financial turnaround and re-list on one of the major exchanges, which may boost the shares as well. With the price a bit low here, I'll definitely consider filling out my position early in the year.
Labels: CCEL











